A group of 4-[3-(1-methoxycarbonyl-1,6-dihydropyridyl)]-derivatives of alkyl 1,4-dihydro-2,6-dimethyl-3-nitro-5-pyridinecarboxylates 8a-e were synthesized by the regioselective reduction of the corresponding 4-(3-pyridyl)-analogs in the presence of methyl chloroformate using Li(tBuO)3AlH. Alternatively, a related group of 4-[3-(1-methoxycarbonyl-4-substituted-1,4-dihydropyridyl)]-compounds 14-18 were prepared using a modified Hantzsch reaction involving the condensation of 1-methoxycarbonyl-4-substituted-1,4-dihydropyridyl-3-carboxaldehydes 11a-c with an alkyl 3-aminocrotonate 12 and nitroacetone 13. In contrast to the 4-(3-pyridyl)-compound 2b, which exhibits an undesirable calcium channel agonist smooth muscle failure.
Introduction
The design of cardioselective Hantzsch 1,4-dihydropyridine (DHP) L-type voltage sensitive calcium channel (CC) agonist positive inotropes has presented a significant challenge to medicinal chemistrs. [1] [2] [3] Accordingly, the prototype 1,4-DHP CC agonist (S)-(+)-Bay K 8644 1 simultaneously promotes calcium entry into vascular smooth muscle, inducing vasconstriction, that prevents its clinical use for the treatment of congestive heart failure (CHF). [4] [5] Recently, we discovered a novel third generation class of isomeric isopropyl 1,4-dihydro-2,6-dimethyl-3-nitro-4-(pyridyl)-5-pyridinecarboxylates 2a-c with different CC modulation activities. 6 The 2-pyridyl One of the most widely used methods to prepare 1,4-DHPs involves the addition of a nucleophile to activated N-alkyl-or N-acylpyridinium salts. [10] [11] [12] The 1,4-versus 1,2-regioselectivity of this reaction is dependent upon the activating N-substituent, the nucleophile, and the nature and position of pyridinium substituents. 10 In the case of N-acylpyridinium salts, optimal 1,4-selectivity, using organometallic reagents, was obtained for organocopper reagents.
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The copper catalyzed reaction of a Grignard reagent with an activated pyridine was first reported by Loev et al. 13 A related reaction for the synthesis of 1,4-DHPs employing an organocuprate reagent was reported later by Piers et al. 14 Subsequently, Comins et al. 15 showed that reaction of an N-alkoxycarbonylpyridinium salt with a Grignard reagent in the presence of a catalytic amount of CuI resulted in nearly exclusive formation of the 1,4-DHP product. In this study, attempts to synthesize the novel class of unsymmetrical 1,4-DHP derivatives 14-18a-c by reaction of the pyridine derivatives 6 with an organocuprate reagent (n-BuMgBr + CuI),
Grignard reagent (n-BuMgBr) or cadmium reagent (n-BuMgBr + CdCl 2 ) in the presence of MeOCOCl were not successful. This failure is attributed to an interaction between the 1,4-DHP nitro substituent of compounds 6 and the organometallic reagent since an earlier study showed that similar reactions employing dialkyl 1,4-dihydro-2,6-dimethyl-4-(3-pyridyl)-3,5-pyridinedicarboxylates proceeded as expected to afford the corresponding 4-[3-(1-methoxycarbonyl-1,4-dihydropyridyl)] products in good yield. 16 An alternate synthetic strategy was therefore employed to by-pass the detrimental effect of the nitro group in compounds 8 starting from the 1-methoxycarbonyl-1,4-dihydropyridyl-3-carboxaldehyde 11. In this regard, reaction 15 , 17 of the ketal 9 with MeOCOCl and a Grignard reagent in the presence of Me 2 S and CuI afforded the 1,4-DHP ketal derivative 10, which on deprotection using 5% HCl, yielded the target 1-methoxycarbonyl-4-substituted-1,4-dihydropyridyl-3-carboxaldehydes 11a-c as illustrated in Scheme 2. The subsequent condensation of an aldehyde 11 with the alkyl 3-aminocrotonate 12 and nitroacetone 13, using a modified Hantzsch reaction, 6 afforded the respective alkyl 1,4-dihydro-2,6-dimethyl-3-nitro-4- 
In vitro calcium channel modulation structure-activity relationships
Changes in the substitution pattern at the C-3, C-4, and C-5 positions of modified Hantzsch 3-nitro-1,4-dihydropyridine calcium channel modulators are determinants of the C-4 heteroaryl rotamer orientation, global conformation, potency and tissue selectivity. 6, 8 The objective of this study was to determine whether elaboration of the planar 4-(3-pyridyl) substituent of 2b to a as indicated in Table 1 ]. Although compounds 8 and 14-18 were less potent calcium channel agonist positive inotropes on heart than the reference drug Bay K 8644, both classes of compounds retained positive cardiac inotropic acitivity (see Table 1 
Experimental Section
General Procedures.
Melting points were determined using a Thomas-Hoover capillary apparatus and are uncorrected. 1 H NMR spectra were recorded using a Bruker AM-300 spectrometer, and the assignment of exchangeable protons (NH) was confirmed by the addition of D2O. Infrared spectra (IR) were acquired using a Nicolet 550-FT spectrometer. Microanalyses were performed by the Microanalytical Services Laboratory, Department of Chemistry, University of Alberta.
Silica gel column chromatography was carried out using Silicyle 7734 (70-230 mesh) silica gel.
Preparative silica gel thin layer chromatography was performed with Macherey-Nagel silica gel.
Dihydropyridines 6a-e, 6 acetal 9 
methoxycarbonyl-1,6-dihydropyridyl)]-5-pyridincarboxyates 8a-e
A solution of Li(t-BuO) 3 AlH in THF (1 mL of 1M) was added to a solution of the respective pyridyl compound 6a-e (1 mmol) in dry THF (15 mL) at -78 °C with stirring. After 10 min, a solution of MeOCOCl (94.5 mg, 1 mmol) in THF (10 mL) was added drop wise via a syringe during 10 min, and the reaction was allowed to proceed at -78 °C for 5 h with stirring. The reaction mixture was allowed to warm to 0 °C, a saturated solution of aqueous NH 4 Cl (10 mL) was added to quench the reaction, and the mixture was poured onto water (50 mL). Extraction with CH2Cl2 (5 x 25 mL), drying the CH 2 Cl 2 extract (Na 2 SO 4 ), and removal of the solvent in vacuo afforded a yellow residue. Purification by silica gel column chromatography using EtOAchexane (3:7, v/v) as eluant yielded the respective product 8a-e. The physical, spectral and microanalytical data for 8a-e are listed below. In the 1 H NMR spectral data, the protons of the C-4 1,4-dihydropyridyl ring system are designated by prime numbers.
Methyl 1,4-dihydro-2,6-dimethyl-3-nitro-4-[3-(1-methoxycarbonyl-1,6-dihydropyridyl)]-5-pyridinecarboxyate (8a).
Yield water (10 mL). The organic fraction was dried (Na 2 SO 4 ) and the solvent was removed in vacuo at 25 °C to give a yellow oil that was purified by preparative silica gel thin layer chromatography
Methyl 1,4-dihydro-2,6-dimethyl-3-nitro-4-[3-(1-methoxycarbonyl-4-methyl-

1,4-dihydropyridyl)]-5-pyridinecarboxylate (14a).
Yield 
Ethyl 1,4-dihydro-2,6-dimethyl-3-nitro-4-[3-(1-methoxycarbonyl-4-methyl-
1,4-dihydropyridyl)]-5-pyridinecarboxylate (15a).
Isopropyl 1,4-dihydro-2,6-dimethyl-3-nitro-4-[3-(1-methoxycarbonyl-4-methyl-1,4-dihydropyridyl)]-
5-pyridinecarboxylate (16a).
Methyl 1,4-dihydro-2,6-dimethyl-3-nitro-4-[3-(1-methoxycarbonyl-4-n-butyl-1,4-dihydropyridyl)]-5-pyridinecarboxylate (14b).
Yield 4-dihydro-2,6-dimethyl-3-nitro-4-[3-(1-methoxycarbonyl-4-n-butyl-1,4-dihydropyridyl) 1,4-dihydro-2,6-dimethyl-3-nitro-4-[3-(1-methoxycarbonyl-4-n-butyl-1,4-dihydropyridyl) Isopropyl 1,4-dihydro-2,6-dimethyl-3-nitro-4-[3-(1-methoxycarbonyl-4-phenyl-1,4-dihydropyridyl) In vitro calcium channel antagonist and agonist assays Calcium channel antagonist activity was determined as the molar concentration of the test compound required to produce 50% inhibition of the muscarinic receptor-mediated (carbachol, 1.67 x 10 -7 M) Ca
t-Butyl
2+
-dependent contraction (tonic response) of guinea pig ileum longitudinal smooth muscle (GPILSM) using the procedure previously reported. 9 The IC 50 value (± SEM), n = 3) was determined graphically from the dose-response curve.
Calcium channel agonist activity (positive inotropic effect on heart) was determined as the percentage (%) increase in contractile force of isolated guinea pig left atrium (GPLA) induced by a 4.46 x 10 -5 M (maximum concentration used) test compound concentration relative to its basal contractile force in the absence of test compound. 
